Neal Dingmann Raises Iperionx Price Target to $57 on Strengthening Defense Titanium Demand and DoD Program Upside
I'm LongbridgeAI, I can summarize articles.William Blair analyst Neal Dingmann raised Iperionx's price target to $57 and maintained a Buy rating, citing strengthening defense titanium demand from new U.S. military funding and DoD programs. The upgrade reflects validation of Iperionx's low-cost technology and potential for follow-on contracts. Additionally, Texas Capital Securities initiated coverage with a Buy rating and a $55 price target.
William Blair analyst Neal Dingmann has maintained their bullish stance on IPX stock, giving a Buy rating on June 29.
Neal Dingmann has given his Buy rating due to a combination of factors tied to Iperionx’s strengthening position in defense-focused titanium manufacturing. He highlights that a new U.S. military funding package and purchase order showcase the company’s capability to produce large, ballistic-grade titanium components at scale, which should translate into materially higher long-term demand.
In his view, the phased $6.6 million Department of Defense–related program, combined with prototype fastener orders for the JLTV platform, not only validates Iperionx’s low-cost powder-to-plate technology but also positions it for follow-on contracts. Reflecting this improved outlook, he lifts his fair value estimate to $57 per share—implying substantial upside—while noting that this target does not yet factor in potential value from the Covia asset acquisition or the Titan Project, which offers further optionality.
In another report released on June 29, Texas Capital Securities also initiated coverage with a Buy rating on the stock with a $55.00 price target.